Illucidx Ultra-Sensitive Diagnostics
medical devices
About
Headquartered in Calgary, Alberta, Canada we hope to enable broad access to the technology of ultrasensitive diagnostics tools for resource-limited settings across the globe. We are currently working on a cartridge-based COVID-19 test to provide much needed rapid and accurate diagnostics in the fight against the globals COVID-19 pandemic. Illucidx continues to perfect our ultra-sensitive near-patient malaria diagnostics designed for deployment in malaria-endemic resource-limited countries.
Technologies
Google Cloud Hosting
Mobile Friendly
Varnish
Wix
Keywords
biosensor integration
cost-effective diagnostic tools
diagnostic chemistry development
biosensor technology
high throughput diagnostic chemistry
covid-19 dx
biosensor development
field deployable tests
covid-19 rapid testing
field diagnostics for tropical diseases
diagnostic cartridges
clinical outcomes
biomaterials
services
nucleic acid testing
biosensor validation
lamp/isothermal amplification
point-of-care molecular testing
biotechnology
ultra-sensitive diagnostics
biosensor testing
sample extraction
isothermal amplification for infectious diseases
malaria detection in low-resource settings
biosensor fabrication
shelf-stable diagnostic tests
pathogen detection
healthcare technology
rapid diagnostics
low-cost diagnostic solutions
Company Information
-
Employees 1
-
Founded 2019
Location
Calgary, Alberta, Canada, T2L 1Y8
